Bharat Biotech’s Nasal Vaccine ‘iNCOVACC’ To Be Available at Rs 325 for Govt Hospitals

Bharat Biotech’s “iNCOVACC” is the world’s first Intranasal vaccine for COVID to receive approval for the primary 2-dose schedule, and as a heterologous booster dose. Bharat Biotech International (BBIL) announced that iNCOVACC (BBV154), is scheduled to be introduced in the country as a booster dose shortly. iNCOVACC is now available on CoWin, and priced at Rs 800+GST for private markets and priced at Rs 325+GST for supplies to Govt of India and State Governments.

Buy Prime Test Series for all Banking, SSC, Insurance & other exams

More About This Development:

Bharat Biotech received approval from the Central Drugs Standard Control Organization (CDSCO) for the use of heterologous booster doses of iNCOVACC.

Technical Side of iNCOVACC:

iNCOVACC is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion-stabilized SARS-CoV-2 spike protein. This vaccine candidate was evaluated in phases I, II and III clinical trials with successful results. iNCOVACC has been specifically formulated to allow intranasal delivery through nasal drops. The nasal delivery system has been designed and developed to be cost-effective in low- and middle-income countries. iNCOVACC was developed in partnership with Washington University, St. Louis, which had designed and developed the recombinant adenoviral vectored construct and evaluated in preclinical studies for efficacy.

Its Significance:

As a needle-less vaccination, Bharat Biotech’s iNCOVACC will be India’s first such booster dose. iNCOVACC’s manufacturing platform has the double benefit of enabling faster development of variant-specific vaccines and easy nasal delivery that enables mass immunization to protect from emerging variants of concern.

Clinical trials were conducted to evaluate iNCOVACC as a primary dose schedule, and as heterologous booster dose for subjects who have previously received two doses of the two commonly administered COVID vaccines in India. iNCOVACC is stable at 2-8 deg C for easy storage and distribution. 

More Sci-Tech News Here

 

 

Piyush Shukla

Recent Posts

Ladakh to Get Autonomous Hill Councils in All Seven Districts: What Article 371 Means

The central government set to strengthen the local self-government in Ladakh has received positive response…

51 minutes ago

MeitY Releases Digital Threat Report 2025–26 to Strengthen Cybersecurity in India’s BFSI Sector

As India's digital financial ecosystem continues to expand rapidly, cyber threats are becoming more sophisticated,…

2 hours ago

UN’s First Scientific Report on AI Warns Governments to Act Before It’s Too Late

As artificial intelligence (AI) is growing faster than before, but the ability to monitor and…

3 hours ago

India Notifies TRQ Allocation Procedure Under India-Oman CEPA

The procedure for the allocating of Tariff Rate Quota (TRQ) allocations has been formally announced…

3 hours ago

Gujarat’s Unjha Cumin and Fennel Receive GI Tag

For Gujarat agriculture sector, Geographical Indication (GI) tag awarded to Unjha cumin (Jeera) and Unjha…

3 hours ago

Centre Renames Central Vista as Kartavya Bhawan Areas

The Government of India has renamed the Central Vista redevelopment area as the Kartavya Bhawan…

4 hours ago